Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Clinical Utility
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Oral therapy combination yields promising results in multiple myeloma study
A new agent that can be taken once daily in pill form showed promising results in a clinical trial when used in combination with a steroid in patients with multiple myeloma who had relapsed and stopped responding to currently available therapies.
September 1, 2023
Grail partners with LGBTQ+ group on study of cancer detection blood test
Grail has partnered with the Whitman-Walker Institute and the Cancer Support Community to assess the feasibility of using its multicancer early detection (MCED) Galleri blood test in a real-world setting.
September 1, 2023
Pfizer invests $25M to support development of CellCentric’s blood cancer candidate
Evidence of the roles p300 and CBP play in multiple cancers led CellCentric to generate chemical hits against the proteins, ultimately leading to the development of inobrodib.
July 13, 2023
Bio-Techne announces interim results on prostate test long-term study
In the prospective, randomized study, researchers are assessing the clinical outcomes of 1,049 men ages 50 and over who have prostate specific antigen (PSA) in the gray zone of uncertain prostate cancer risk.
May 18, 2023
Clinical investigators need to be wary of confounding and bias in real-world studies; here is what to look for and how to address it
Clinical investigators need to look out for confounding and bias associated with real-world data in randomized trials and observational studies used to produce real-world evidence (RWE) to assess the safety and efficacy of an intervention.
March 17, 2023
After Illumina presentation highlighting Grail potential comes a possible EU fine
At the J.P. Morgan healthcare event this week, Illumina's CEO said Grail must be operated separately and independently pursuant to measures required by the EU.
January 12, 2023
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
Biological Dynamics said that it is collaborating with Qure Healthcare and Curta to also evaluate the effects of its pancreatic cancer detection assay on patient outcomes and healthcare economics.
November 23, 2022
Roche points to results of heart failure study leveraging its cardiac hormone biomarker and test
The results were shared this week at an American Heart Association Late-Breaking Scientific Session and published simultaneously in the Lancet.
November 9, 2022
Self-supervised deep learning algorithm shows promise for rapid whole-slide-imaging retrieval
Brigham and Women’s Hospital researchers are developing an algorithm to speed whole-slide-imaging retrieval from large digital repositories.
October 19, 2022
Prelude Dx to present clinical utility data for DCIS risk assessment test
DCISionRT predicts radiation therapy benefit through a risk assessment test for patients with ductal carcinoma in situ (DCIS).
October 21, 2022
Interpace Biosciences announces data for test to assess indeterminate thyroid nodules
The data support both versions of its test platform and a blinded analysis of pairwise miRNA expression profiling demonstrated greater accuracy than its original testing platform, the firm said.
October 21, 2022
Page 1 of 2
Next Page
